Duggan Robert W's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Jul 9, 2024
- Accession no.
- 0001437749-24-022358
- Filed
- Jul 9, 2024
- Trade date
- Jul 3, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 6 derivative transactions. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duggan Robert WCIK 0001055919 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Common Stock | XIn-the-money exerciseAcquired | +5,187,824 | – | – | 42,172,003 | Direct | |
| Jul 3, 2024 | Common Stock | XIn-the-money exerciseAcquired | +69,020 | – | – | 561,089 | Indirect | |
| Jul 3, 2024 | Common Stock | XIn-the-money exerciseAcquired | +49,312 | – | – | 400,877 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +2,593,912 | – | – | 2,593,912 | Direct | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +2,593,912 | – | – | 2,593,912 | Direct | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +34,510 | – | – | 34,510 | Indirect | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +34,510 | – | – | 34,510 | Indirect | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +24,656 | – | – | 24,656 | Indirect | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +24,656 | – | – | 24,656 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.